Health
Dexamethasone drug may not benefit COVID-19 patients with diabetes or low albumin levels – News-Medical.Net
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
A new discovery about how the body transports dexamethasone, a drug that can increase the survival chances of patients with severe COVID-19, suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.
Based on their findings, the researchers say doctors may need to rethink how they dose the drug for certain groups of patients.
The team of scientists, based at the University of Virginia School of Medicine, the University of…
-
Noosa News15 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General19 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News23 hours agoTributes flow for Geham wife and mother after husband charged with murder
-
Noosa News15 hours agoHow to find out your TikTok personality – and become a ‘citizen scientist’